A focused review on technologies, mechanisms, safety, and efficacy of available COVID-19 vaccines
P Ghasemiyeh, S Mohammadi-Samani… - International …, 2021 - Elsevier
20 months has been passed since the detection of the first cases of SARS-CoV-2 infection
named COVID-19 from Wuhan city of China. This novel coronavirus spread rapidly around …
named COVID-19 from Wuhan city of China. This novel coronavirus spread rapidly around …
Heterologous prime–boost strategies for COVID-19 vaccines
Abstract Background/Objective Heterologous prime–boost doses of COVID-19 vaccines
('mix-and-match'approach) are being studied to test for the effectiveness of Oxford …
('mix-and-match'approach) are being studied to test for the effectiveness of Oxford …
SARS-CoV-2 mRNA vaccine induces robust specific and cross-reactive IgG and unequal neutralizing antibodies in naive and previously infected people
TM Narowski, K Raphel, LE Adams, J Huang, NA Vielot… - Cell reports, 2022 - cell.com
Understanding vaccine-mediated protection against severe acute respiratory syndrome
coronavirus-2 (SARS-CoV-2) is critical to overcoming the global coronavirus disease 2019 …
coronavirus-2 (SARS-CoV-2) is critical to overcoming the global coronavirus disease 2019 …
Reduced titers of circulating anti-SARS-CoV-2 antibodies and risk of COVID-19 infection in healthcare workers during the nine months after immunization with the …
L Coppeta, C Ferrari, G Somma, A Mazza, U D'Ancona… - Vaccines, 2022 - mdpi.com
The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pandemic has had a
tremendous impact on health services; hundreds of thousands of healthcare workers …
tremendous impact on health services; hundreds of thousands of healthcare workers …
[HTML][HTML] Humoral and cellular immune responses to SARS-CoV-2 mRNA vaccination in patients with multiple sclerosis: an Israeli multi-center experience following 3 …
R Milo, E Staun-Ram, D Karussis, A Karni… - Frontiers in …, 2022 - frontiersin.org
Background Immunomodulatory/immunosuppressive activity of multiple sclerosis (MS)
disease modifying therapies (DMTs) might affect immune responses to SARS-CoV-2 …
disease modifying therapies (DMTs) might affect immune responses to SARS-CoV-2 …
Lack of vitamin D predicts impaired long-term immune response to COVID-19 vaccination
L di Filippo, S Frara, U Terenzi, F Nannipieri… - Endocrine, 2023 - Springer
Purpose Low vitamin D levels were reported to negatively influence the outcome of acute
COVID-19, as well as to be linked to Long-COVID. However, few studies have investigated …
COVID-19, as well as to be linked to Long-COVID. However, few studies have investigated …
Heterogenous CD8+ T cell maturation and 'polarization'in acute and convalescent COVID-19 patients
IV Kudryavtsev, NA Arsentieva, ZR Korobova… - Viruses, 2022 - mdpi.com
Background. The adaptive antiviral immune response requires interaction between CD8+ T
cells, dendritic cells, and Th1 cells for controlling SARS-CoV-2 infection, but the data …
cells, dendritic cells, and Th1 cells for controlling SARS-CoV-2 infection, but the data …
Immunity after COVID-19 and vaccination: follow-up study over 1 year among medical personnel
V Glück, S Grobecker, J Köstler, L Tydykov, M Bertok… - Infection, 2021 - Springer
Background The long-term course of immunity among individuals with a history of COVID-
19, in particular among those who received a booster vaccination, has not been well defined …
19, in particular among those who received a booster vaccination, has not been well defined …
Changes in anti-SARS-CoV-2 IgG subclasses over time and in association with disease severity
ZR Korobova, EV Zueva, NA Arsentieva, OK Batsunov… - Viruses, 2022 - mdpi.com
IgG is the most prominent marker of post-COVID-19 immunity. Not only does this subtype
mark the late stages of infection, but it also stays in the body for a timespan of at least 6 …
mark the late stages of infection, but it also stays in the body for a timespan of at least 6 …
Immunogenicity and safety of two doses of the CoronaVac SARS-CoV-2 vaccine in SARS-CoV-2 seropositive and seronegative patients with autoimmune rheumatic …
Background We aimed to examine the immunogenicity pattern induced by the inactivated
SARS-CoV-2 vaccine CoronaVac (Sinovac Life Sciences, Beijing, China) in SARS-CoV-2 …
SARS-CoV-2 vaccine CoronaVac (Sinovac Life Sciences, Beijing, China) in SARS-CoV-2 …